Zura Bio Limited Class A Ordinary Shares (ZURA)
Healthcare
Biotechnology
5.50 $
+1.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Zura Bio Limited Class A Ordinary Shares (ZURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.2 | -2.6 | -4.1 | -5.0 | -6.6 | -5.7 | -11 | -11 | -16 | -15 | -22 | -19 | -73 | |
| – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 2.3 | 2.6 | 2.4 | 2.4 | 2.9 | 8.6 | 2.8 | 3.6 | 3.7 | 2.4 | 2.6 | 5.0 | 14 | |
| -1.0 | 2.8 | 3.0 | -0.2 | 0.0 | 2.5 | 0.0 | 2.7 | -3.8 | 0.2 | -2.7 | 0.3 | -6.1 | |
| 5.8 | 2.3 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -5.8 | -2.3 | – | -5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| – | – | – | – | – | – | – | – | 0.0 | – | – | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 80 | -4.1 | 0.0 | 0.0 | 105 | 5.4 | -0.9 | 5.2 | 0.0 | 0.0 | -7.3 | 135 | 128 | |
| 69 | -8.9 | -4.1 | -10.0 | 99 | -0.2 | -12 | -5.9 | -16 | -15 | -30 | 116 | 55 | |
| -11 | -4.8 | -4.1 | -10.0 | -6.6 | -5.7 | -11 | -11 | -16 | -15 | -22 | -19 | -73 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.